You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BBI608, thymic cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Kashiwa, Chiba, Nagoya, Aichi (BBI608, 5-FU, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Kashiwa, Chiba, Japan
  • +1 more
Apr 9, 2022

Glioblastoma Trial in New York, Calgary, Toronto (BBI608, Temozolomide)

Completed
Has Results
  • Glioblastoma
  • New York, New York
  • +2 more
Apr 4, 2022

Cancer Trial in United States (BBI608, Ipilimumab, Nivolumab)

Completed
  • Cancer
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

Completed
  • Hematologic Malignancy
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Cancer, Advanced Solid Tumors Trial in United States (BBI608, BBI503)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +10 more
Apr 4, 2022

Cancer, Advanced Malignancies Trial in Greenville, Ottawa, Montreal (BBI608)

Completed
  • Cancer, Advanced Malignancies
  • Greenville, South Carolina
  • +2 more
Apr 4, 2022

Colorectal Cancer Trial in United States (BBI608, Panitumumab, Capecitabine)

Completed
Has Results
  • Colorectal Cancer
  • Scottsdale, Arizona
  • +12 more
Apr 4, 2022

Metastatic Pancreatic Adenocarcinoma Trial in United States (BBI608, Nab-paclitaxel, Gemcitabine)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Phoenix, Arizona
  • +11 more
Apr 4, 2022

NSCLC Trial in United States (Napabucasin, Paclitaxel)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +4 more
Apr 4, 2022

Hepatocellular Carcinoma Trial in United States (BBI608, BBI503, Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Gilbert, Arizona
  • +28 more
Apr 4, 2022

Metastatic Colorectal Cancer Trial in Kashiwa (Napabucasin, Pembrolizumab)

Terminated
  • Metastatic Colorectal Cancer
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
Aug 30, 2021

Oncology Trial in Worldwide (Napabucasin, Nab-paclitaxel, Gemcitabine)

Completed
  • Oncology
  • Atlanta, Georgia
  • +6 more
Apr 4, 2022

Colorectal Cancer Metastatic Trial in Australia (Nivolumab 10 MG/ML, BNC 105, BBI608)

Completed
  • Colorectal Cancer Metastatic
  • Nivolumab 10 MG/ML
  • +2 more
  • Albury, New South Wales, Australia
  • +13 more
Aug 26, 2021

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)

Completed
Has Results
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Scottsdale, Arizona
  • +262 more
Apr 4, 2022

Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Birmingham, Alabama
  • +210 more
Mar 30, 2022

Thymic Malignancies, Pleural Metastases Trial in United States (Intensity-Modulated Pleural Radiation Therapy (IMPRINT))

Recruiting
  • Thymic Malignancies
  • Pleural Metastases
  • Intensity-Modulated Pleural Radiation Therapy (IMPRINT)
  • Basking Ridge, New Jersey
  • +6 more
May 2, 2022

Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

Recruiting
  • Thymic Carcinoma
  • Envolizumab combined with radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 3, 2023

Carcinoma, Pancreatic Ductal Trial in Worldwide (Napabucasin, Nab-paclitaxel, Gemcitabine)

Completed
Has Results
  • Carcinoma, Pancreatic Ductal
  • Birmingham, Alabama
  • +266 more
Apr 4, 2022

Colorectal Carcinoma Trial in Australia, Canada, Japan (BBI608, Placebo, Best Supportive Care)

Completed
Has Results
  • Colorectal Carcinoma
  • Bankstown, New South Wales, Australia
  • +62 more
Apr 2, 2020

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

Recruiting
  • Stage III Thymoma AJCC v8
  • +6 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

Active, not recruiting
  • Thymic Carcinoma
  • +3 more
  • VEGFR/PDGFR Dual Kinase Inhibitor X-82
  • Nivolumab
  • Palo Alto, California
  • +6 more
Sep 21, 2022

First-episode Psychosis Trial in France (Recorded interview, Clinical scales, Blood sample)

Not yet recruiting
  • First-episode Psychosis
  • Recorded interview
  • +3 more
  • Angers, France
  • +5 more
Dec 29, 2022